| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.58 | 0.04 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.47 | 0.09 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.4 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.27 | 4e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.26 | 3e-05 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.23 | 2e-09 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.21 | 0.001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.2 | 0.002 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.19 | 0.0006 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-05 |